Janssen Vaccines &； Prevention B.V.;Beth Israel Deaconess Medical Center, Inc.;Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.;THE GOVERNMENT OF THE UNITED STATES, AS RE
发明人:
Frank TOMAKA,Maria Grazia PAU,Johanna SCHUITEMAKER,Dan BAROUCH,Jintanat ANANWORANICH,Merlin ROBB,Nelson L. MICHAEL,Jerome KIM
申请号：
US16385062
公开号：
US20190247491A1
申请日:
2019.04.16
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Methods for inducing an immune response against Human Immunodeficiency Virus (HIV) in HIV-infected subjects undergoing antiretroviral therapy (ART) are described. The methods include administering an adenovirus vector primer vaccine and a modified vaccinia virus (MVA) vector booster vaccine encoding mosaic HIV antigens.
